Hypertension and Heart Failure with Preserved Ejection Fraction
- PMID: 34051966
- DOI: 10.1016/j.hfc.2021.02.002
Hypertension and Heart Failure with Preserved Ejection Fraction
Abstract
The prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing rapidly, and its prognosis is as poor as that of HF with reduced EF. Hypertension is an important risk factor involved in the pathophysiology of HFpEF. Although treatment of hypertension lowers the incidence of HF and is beneficial in patients with HFpEF, there is conflicting evidence on this topic. This article discusses the pathophysiological mechanisms linking hypertension with HFpEF and also the current evidence on the treatment of hypertension in patients with HFpEF.
Keywords: Antihypertensive agents; Blood pressure; Heart failure; Hypertension.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to declare. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT (NRF-2020R1C1C1013627) and was also supported by Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2017R1D1A1B03034053).
Similar articles
-
Hypertension and Heart Failure with Preserved Ejection Fraction: Connecting the Dots.Curr Vasc Pharmacol. 2017;16(1):15-22. doi: 10.2174/1570161115666170414120532. Curr Vasc Pharmacol. 2017. PMID: 28413968 Review.
-
Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.ESC Heart Fail. 2019 Oct;6(5):1057-1067. doi: 10.1002/ehf2.12500. Epub 2019 Jul 19. ESC Heart Fail. 2019. PMID: 31325235 Free PMC article.
-
The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more?Heart Fail Rev. 2018 Sep;23(5):631-639. doi: 10.1007/s10741-018-9698-8. Heart Fail Rev. 2018. PMID: 29619635 Review.
-
Treatment of hypertension in heart failure with preserved ejection fraction.Curr Hypertens Rev. 2014;10(3):142-8. doi: 10.2174/1573402111666141217112216. Curr Hypertens Rev. 2014. PMID: 25544287 Review.
-
Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.Heart Fail Rev. 2019 Nov;24(6):847-866. doi: 10.1007/s10741-019-09804-2. Heart Fail Rev. 2019. PMID: 31147814 Review.
Cited by
-
Global status and trends in heart failure with preserved ejection fraction over the period 2009-2020: A bibliometric analysis.Medicine (Baltimore). 2022 Mar 18;101(11):e29106. doi: 10.1097/MD.0000000000029106. Medicine (Baltimore). 2022. PMID: 35356948 Free PMC article.
-
Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: A systematic review focused on defining high risk phenogroups.EXCLI J. 2022 Feb 22;21:487-518. doi: 10.17179/excli2021-4572. eCollection 2022. EXCLI J. 2022. PMID: 35391918 Free PMC article. Review.
-
A Revolutionary Blueprint for Mitigation of Hypertension via Nanoemulsion.Biomed Res Int. 2022 Apr 14;2022:4109874. doi: 10.1155/2022/4109874. eCollection 2022. Biomed Res Int. 2022. PMID: 35463984 Free PMC article. Review.
-
Blood pressure and heart failure: focused on treatment.Clin Hypertens. 2024 Jun 1;30(1):15. doi: 10.1186/s40885-024-00271-y. Clin Hypertens. 2024. PMID: 38822445 Free PMC article. Review.
-
Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction.Circ Res. 2024 Aug 16;135(5):614-628. doi: 10.1161/CIRCRESAHA.124.324706. Epub 2024 Jul 16. Circ Res. 2024. PMID: 39011638 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous